Search Ontology:
ChEBI

abexinostat

Term ID
CHEBI:92223
Synonyms
  • 3-[(dimethylamino)methyl]-N-[2-[4-(hydroxycarbamoyl)phenoxy]ethyl]-1-benzofuran-2-carboxamide
  • 3-[(dimethylamino)methyl]-N-[2-[4-[(hydroxyamino)-oxomethyl]phenoxy]ethyl]-2-benzofurancarboxamide
  • 3-[(dimethylamino)methyl]-N-[2-[4-[(hydroxyamino)carbonyl]phenoxy]ethyl]-2-benzofurancarboxamide
  • 3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl)phenoxy]ethyl}-1-benzofuran-2-carboxamide
  • abexinostat
  • abexinostatum
  • CRA 024781
  • CRA 24781
  • CRA-024781
  • PCI 24781
  • PCI-24781
  • PZP-115891
  • PZP115891
  • S-78454
  • S78454
Definition
A 1-benzofuran substituted by {2-[4-(hydroxycarbamoyl)phenoxy]ethyl}aminocarbonyl and (dimethylamino)methyl groups at positions 2 and 3, respectively. It is a potent pan-HDAC inhibitor whose major target is HDAC1 (Ki = 7 nM).
References
  • agr:IND605480874
  • cas:783355-60-2
  • drugbank:DB12565
  • hmdb:HMDB0256171
  • kegg.drug:D10060
  • lincs.smallmolecule:LSM-2269
  • pmc:PMC4144576
  • pubmed:16731764
  • pubmed:18006784
  • pubmed:18042714
  • pubmed:19417021
  • pubmed:19417023
  • pubmed:20145726
  • pubmed:20461381
  • pubmed:21508354
  • pubmed:22326466
  • pubmed:23724141
  • pubmed:23737346
  • pubmed:23790467
  • pubmed:23977108
  • pubmed:24312289
  • pubmed:25110436
  • pubmed:25505847
  • pubmed:25520806
  • pubmed:25782916
  • pubmed:26750740
  • pubmed:27095947
  • pubmed:27271328
  • pubmed:28915585
  • pubmed:32534122
  • pubmed:33500709
  • pubmed:34696786
  • pubmed:38378603
  • wikipedia.en:Abexinostat
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from abexinostat
Phenotype where environments contain abexinostat
Phenotype modified by environments containing abexinostat
Phenotype affecting abexinostat
Human Disease Model